Trials / Approved For Marketing
Approved For MarketingNCT06500598
Compassionate Use of Evinacumab
- Status
- Approved For Marketing
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Regeneron Pharmaceuticals · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Provide compassionate use of evinacumab
Detailed description
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications. Availability will depend on location.
Conditions
- Pediatric Homozygous Familial Hypercholesterolemia (HoFH)
- Severe Hypertriglyceridemia (HTG)
- Dysbetalipoproteinemia (DBL)
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Evinacumab |
Timeline
- First posted
- 2024-07-15
- Last updated
- 2025-10-28
Source: ClinicalTrials.gov record NCT06500598. Inclusion in this directory is not an endorsement.